Related Experiment Videos
A checklist for evaluating reports of expression profiling for treatment selection
1Division of Cancer Treatment & Diagnosis, National Cancer Institute, Bethesda, MD 20892-7434, USA. rsimon@nih.gov
Clinical Advances in Hematology & Oncology : H&O
|May 27, 2006
Summary
Oncologists require better tools for personalized cancer treatment selection. A new checklist aids in evaluating gene expression profiling studies for clinical application in human tumors.
Area of Science:
- Oncology
- Bioinformatics
- Translational Medicine
Background:
- Many cancer patients do not respond to current therapies, necessitating improved treatment selection strategies.
- Gene expression profiling of tumors is increasingly used for treatment guidance, but its clinical utility requires careful evaluation.
- Evaluating complex, statistics-intensive studies on gene expression signatures presents a challenge for practicing oncologists.
Purpose of the Study:
- To provide oncologists with a tool to critically assess published research on gene expression profiling in human tumors.
- To help determine the readiness of expression profiling results for clinical implementation in patient care.
Main Methods:
- Development of a structured checklist for evaluating publications.
- The checklist focuses on key aspects of expression profiling studies relevant to clinical decision-making.
Main Results:
- A checklist designed to assist oncologists in appraising the validity and applicability of gene expression profiling studies.
- The checklist aims to bridge the gap between research findings and clinical practice.
Conclusions:
- The presented checklist can empower oncologists to make more informed decisions regarding the use of gene expression profiling in patient treatment.
- This tool facilitates the critical evaluation of evidence, promoting the responsible integration of novel diagnostic technologies into oncology practice.